Evidence explainer

Women's, men's, and reproductive health

PMS and PMDD: Ordinary Premenstrual Symptoms Versus a Treatable Disorder

Most people who menstruate get some premenstrual symptoms. PMDD is smaller, more severe, and treatable, marked by mood symptoms, cyclic timing, and impairment, and confirmed by daily tracking.

Fully reviewed by Jasaman (Jasmin) Tojjar, MD, PhD

On this page
  1. The short answer
  2. Key points
  3. What is the difference between PMS and PMDD?
  4. What are the symptoms of PMDD?
  5. How do symptom diaries confirm the pattern?
  6. How is PMDD treated?
  7. When to seek care

The short answer#

PMS and PMDD sit on the same spectrum, but they are not the same thing. PMS covers the common physical and mood symptoms that show up in the week or two before a period and settle once bleeding starts. PMDD, premenstrual dysphoric disorder, is a distinct and more severe condition in which mood symptoms (irritability, sudden mood swings, low mood, or anxiety) become intense enough to disrupt work, school, or relationships in most cycles. The dividing lines are severity, functional impairment, and a strictly cyclic pattern confirmed by daily symptom tracking. PMDD affects roughly 3% to 8% of people who menstruate, and it responds to treatment.

Key points#

What is the difference between PMS and PMDD?#

Nearly everyone who menstruates notices something in the days before a period: bloating, breast tenderness, headache, food cravings, tiredness, or a shorter temper. Surveys suggest most people report at least mild premenstrual symptoms, and a smaller share have symptoms troublesome enough to interfere with daily life. That everyday, physical-plus-mild-mood picture is what clinicians mean by PMS.

PMDD is a step change, not just a bad case of PMS. In PMDD the emotional symptoms dominate and become severe: pronounced irritability or anger, mood swings that feel out of your control, hopeless or low mood, and anxiety or tension. What makes it a disorder rather than a rough week is impairment. The symptoms repeatedly damage function, straining relationships, derailing work or school, and pushing daily life off track, then lifting after the period arrives.

Three features do most of the sorting work: severity, timing, and function.

Article data table
FeatureTypical PMSPMDD
TimingLuteal week or two before menses, eases after bleeding startsSame cyclic timing, confirmed by charting
Leading symptomsPhysical symptoms plus mild mood changesSevere mood symptoms (irritability, mood swings, low mood, anxiety)
Number of symptomsOne or moreAt least 5, including one core mood symptom
Effect on functionAnnoying but manageableMarked impairment in work, school, or relationships
How it is confirmedClinical patternDSM-5 criteria plus two cycles of daily ratings

This topic is part of our wider section on Women's, men's, and reproductive health, where premenstrual conditions overlap with contraception, mood, and general primary care.

What are the symptoms of PMDD?#

The DSM-5 framework asks for at least 5 of 11 symptoms during the final week before menses, with the symptoms improving within a few days of bleeding and largely gone in the week after the period. At least one has to be a core mood symptom:

The remaining symptoms fill out the picture and can include reduced interest in usual activities, trouble concentrating, low energy or marked fatigue, changes in appetite or specific food cravings, sleeping too much or too little, a sense of being overwhelmed or out of control, and physical symptoms such as breast tenderness, bloating, joint or muscle aches, or a feeling of weight gain.

Two details matter. First, the count is not a checklist you tally once. The symptoms have to cluster in the luteal phase and cause real distress or interfere with function. Second, PMDD is defined by cyclicity. If low mood or anxiety is present most of the month and simply worsens before a period, that pattern is a premenstrual exacerbation of an underlying condition, not PMDD, and it points toward evaluating for depression or an anxiety disorder. Our guide Depression and Anxiety in Primary Care: What to Expect covers how those conditions are assessed.

How do symptom diaries confirm the pattern?#

Memory is a poor witness here. When people rate their symptoms from recall, the timing blurs, and conditions that run all month can look premenstrual. That is why current guidance leans on prospective daily ratings: you score a short list of symptoms each day for at least two consecutive cycles, then look at whether the peaks really do land in the luteal phase and clear after menses.

Validated tools exist for exactly this. The Daily Record of Severity of Problems (DRSP) tracks the DSM-5 symptoms day by day, and screening instruments such as the Premenstrual Symptom Screening Tool (PSST) help flag who should chart. The point of charting is not paperwork. It is the single step that most reliably distinguishes PMDD from a primary mood or anxiety disorder, from thyroid problems, and from ordinary PMS.

Because PMDD shares so much ground with depression and anxiety, clinicians often pair the diary with standard mood screens. The instruments described in Mental Health Screening Tools: PHQ-9 and GAD-7 Explained can show whether symptoms are truly confined to the luteal phase or are present, at some level, throughout the month. That distinction changes what treatment makes sense.

How is PMDD treated?#

At an educational level, the evidence is strongest for two approaches: SSRIs and structured self-management, often used together. Nothing below is a prescription. It is a map of what trials and guidelines describe so you can have a better conversation with a clinician.

SSRIs (a class of antidepressants) are the best-studied option for PMDD. A 2024 Cochrane review pooling 34 randomized trials in about 4,500 women concluded that SSRIs probably reduce overall premenstrual symptoms, a moderate effect on symptom scales. They can be taken two ways: every day (continuous), or only during the luteal phase, from around ovulation until the period starts (intermittent). The Cochrane analysis found continuous dosing probably works somewhat better than luteal-only dosing. Because SSRIs can act on premenstrual mood within days rather than the weeks needed in depression, the intermittent schedule is a genuine option for some people. Side effects are real: in the pooled trials nausea affected about 1 in 5 users (roughly 20%, versus 7% on placebo) and low energy or fatigue about 1 in 7 (roughly 14%, versus 5% on placebo), with insomnia and sexual side effects also more common than on placebo. That trade-off, faster relief against tolerability, is worth weighing openly.

Combined hormonal contraceptives are the other prescription route people ask about, particularly formulations containing drospirenone, sometimes taken continuously to avoid a monthly hormone drop. The benefit for premenstrual mood symptoms has looked modest and inconsistent in trials, so it is better framed as an option to discuss than a sure fix, especially if contraception is wanted anyway. Our guide Contraception in Primary Care: Methods and How to Choose walks through how these methods are selected.

Non-drug measures carry little downside and belong in most plans. Regular aerobic exercise, protected sleep, and stress reduction are standard advice, and cognitive behavioral therapy has evidence for premenstrual mood symptoms without medical harms. Among supplements, calcium and vitamin B6 are the most commonly cited, but the evidence is limited, and popular herbal products such as chasteberry rest on weaker data. Check with a clinician or pharmacist before starting any supplement, since some interact with medications.

When to seek care#

Some situations call for a clinician sooner rather than later, and one calls for urgent help now.

For a diagnosis or a treatment plan tailored to you, see a qualified clinician who can review your full history.

Sources and further reading

  1. Premenstrual Dysphoric Disorder (StatPearls, NCBI Bookshelf)
  2. Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder (Cochrane Review, 2024)
  3. Benefits and risks of treating PMS and PMDD with SSRIs (Cochrane plain-language summary)
  4. Premenstrual syndrome (PMS) (NHS)
  5. Premenstrual syndrome (PMS) (Office on Women's Health)